Reported Dec 18, 2024 · Ongoing
Levothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-1809-77) and b) 1000-count bottles…
Viatris Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Viatris Inc · 1000 Mylan Blvd · Canonsburg, PA · 15317-5853
Is this the product you have?
- Levothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-1809-77) and b) 1000-count bottles (NDC 0378-1809-10), Rx only
- Manufactured forMylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A
- Lot codes and dates
Lot #: a) 8171269Exp. Date Feb 20258179579Exp. Date July 2025 b)3183815Exp. Date Nov 20243189147Exp. Date Jan 20253192027Exp. Date Feb 20253202894Exp. Date Jul 20253192026Exp. Date Feb 20253199781Exp. Date Jun 2025. 3192028exp. date Feb 2025 3202895exp. date July 2025
- Amount recalled
- 65,169
This recall covers 11 products
The agency filed one notice per product. You are reading one of them; the other 10 are below.
Where it was sold
- Nationwide
- PR
Why it was recalled
Superpotent Drug and Subpotent Drug: potency failures obtained
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Viatris Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.